Choose the modality by haemodynamics, brain risk, resources and cost; understand convection vs diffusion and vascular access.
At the bedside
- 1
Choose by haemodynamics
Shock on vasopressors or needing large fluid removal: CRRT or SLED. Stable patients: IHD. KDIGO: use CRRT and IHD as complementary therapies.
- 2
Brain at risk
Acute liver failure, TBI, cerebral oedema: CRRT preferred (avoids osmotic shifts and hypotension).
- 3
Choose the technique
Convection (CVVH: replacement fluid; better middle-molecule removal) vs diffusion (CVVHD: dialysate) vs both (CVVHDF). Outcome differences are not proven; follow unit practice.
- 4
Vascular access
Non-cuffed dialysis catheter, ultrasound-guided. Preference: right internal jugular (12-15 cm) > femoral (19-24 cm) > left internal jugular (15-20 cm) > subclavian (avoid: stenosis risk for future fistula).
- 5
Prescribe fluid removal
Net ultrafiltration usually 0-2 mL/kg/h, adjusted hourly to haemodynamics; very high net UF (> 1.75 mL/kg/h) associated with worse outcomes in observational data.
- 6
Monitor
Electrolytes (K, PO4, Mg) 6-12 hourly on CRRT, ABG, temperature (CRRT cools), drug levels, circuit pressures.
Modalities compared
| Feature | IHD | SLED / PIRRT | CRRT |
|---|---|---|---|
| Duration | 3-5 h, 3-6x/week | 6-12 h daily | Continuous 24 h |
| Blood flow | 250-400 mL/min | 150-200 mL/min | 150-250 mL/min |
| Haemodynamic stability | Least | Intermediate | Best |
| Raised ICP | Avoid | Caution | Preferred |
| Anticoagulation need | Often none | Low/none | Usually needed (citrate/heparin) |
| Cost in India | Lowest | Low-moderate | Highest (fluids, filters) |
| Drug dosing | Dose after session | Dose after session | Continuous clearance (CrCl ~ 25-50) |
Choosing RRT modality
Step 1 of ~3
Decision: Raised ICP / acute liver failure / cerebral oedema?
Based on Kidney Disease: Improving Global Outcomes (KDIGO) AKI Work Group. Educational use; follow local protocol.
Pathophysiology
Diffusion moves small solutes (urea, K) down a concentration gradient; convection drags solutes with water through the membrane (solvent drag), clearing larger molecules. Slow continuous removal avoids rapid osmotic shifts (dialysis disequilibrium, cerebral oedema) and hypotension.
Evidence
- RCTs and meta-analyses show no mortality difference between CRRT and IHD; CRRT may be associated with better renal recovery in observational data [KDIGO 2012].
Controversies
- CVVH vs CVVHDF; high cut-off membranes; adsorptive filters (oXiris, CytoSorb) in sepsis - unproven.
🇮🇳 India notes
- CRRT costs (filters, bags) run to tens of thousands of rupees per day; SLED with online fluid reduces cost several-fold.
- Many Indian ICUs depend on the hospital dialysis unit for IHD/SLED staffing; agree escalation pathways.
References
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

